Intensive Pharmacy Care Improves Outcomes of Hepatitis C Treatment in a Vulnerable Patient Population at a Safety-Net Hospital.

Ashley N TranRishabh SachdevZachary P FrickerMichael LeberToni ZahorianBhavesh ShahDavid P NunesMichelle T Long

Published in: Digestive diseases and sciences (2018)

HCV treatment with DAA was well tolerated, but the rate of SVR was low (71%) compared to trials. This was due to loss to follow-up, as the per-protocol rate of SVR was much higher (95%). Use of ON-ISP was associated with an increase in SVR and may be valuable for improving care for vulnerable populations.

Keyphrases

healthcare
palliative care
quality improvement
hepatitis c virus
metabolic syndrome
case report
combination therapy
adipose tissue
hiv infected
genetic diversity
drug induced